Marco E. Bianchi

Active 1983–2025

142
Papers
40,852
Citations
101
h-index
140
i10-index

Citations

Citations per year for Marco E. Bianchi1982: 1 citations1983: 1 citations1984: 6 citations1985: 11 citations1986: 4 citations1987: 2 citations1988: 2 citations1989: 7 citations1990: 8 citations1991: 15 citations1992: 14 citations1993: 44 citations1994: 63 citations1995: 45 citations1996: 45 citations1997: 56 citations1998: 72 citations1999: 104 citations2000: 74 citations2001: 106 citations2002: 132 citations2003: 227 citations2004: 252 citations2005: 210 citations2006: 327 citations2007: 432 citations2008: 445 citations2009: 550 citations2010: 657 citations2011: 629 citations2012: 719 citations2013: 650 citations2014: 724 citations2015: 606 citations2016: 552 citations2017: 565 citations2018: 589 citations2019: 1,359 citations2020: 1,627 citations2021: 1,428 citations2022: 1,083 citations2023: 880 citations2024: 1,217 citations2025: 574 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,791 citing papers, 26.1% of this breakdownChina: 2,137 citing papers, 14.7% of this breakdownGermany: 888 citing papers, 6.1% of this breakdownItaly: 842 citing papers, 5.8% of this breakdownUnited Kingdom: 762 citing papers, 5.3% of this breakdownFrance: 621 citing papers, 4.3% of this breakdownJapan: 555 citing papers, 3.8% of this breakdownCanada: 368 citing papers, 2.5% of this breakdownAustralia: 362 citing papers, 2.5% of this breakdownNetherlands: 350 citing papers, 2.4% of this breakdownSweden: 280 citing papers, 1.9% of this breakdownSouth Korea: 278 citing papers, 1.9% of this breakdown
0%26.1%Other 22.7%

Fields

  • Biochemistry, Genetics and Molecular Biology40.6%
  • Medicine30.7%
  • Immunology and Microbiology18.8%
  • Neuroscience5.2%
  • Pharmacology, Toxicology and Pharmaceutics1.3%
  • Engineering1%
  • Other2.4%

Topics

  • Advanced Glycation End Products research5.6%
  • Immune Response and Inflammation3.8%
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms2.8%
  • Immune cells in cancer2.8%
  • Neuroinflammation and Neurodegeneration Mechanisms2.3%
  • Inflammasome and immune disorders2.2%
  • Other80.5%

Coauthors

All papers

Open in search
  1. Apoptotic cell death in disease—Current understanding of the NCCD 2023

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pierluigi Bove, Patricia Boya, Catherine Brenner, Petr Brož, Thomas Brunner, Rune Busk Damgaard, George A. Calin, Michelangelo Campanella, Eleonora Candi, Michele Carbone, Didac Carmona‐Gutiérrez, Francesco Cecconi, Francis Ka-Ming Chan, Guoqiang Chen, Quan Chen, Youhai H. Chen, Emily H. Cheng, Jerry E. Chipuk, John A. Cidlowski, Aaron Ciechanover, Gennaro Ciliberto, Marcus Conrad, Juan R. Cubillos‐Ruiz, Peter E. Czabotar, Vincenzo D’Angiolella, Mads Daugaard, Ted M. Dawson, Valina L. Dawson, Ruggero De Maria, Bart De Strooper, Klaus‐Michael Debatin, Ralph J. DeBerardinis, Alexei Degterev, Giannino Del Sal, Mohanish Deshmukh, Francesco Di Virgilio, Marc Diederich, Scott J. Dixon, Brian David Dynlacht, Wafik S. El‐Deiry, John W. Elrod, Kurt Engeland, Gian María Fimia, Claudia Galassi, Carlo Ganini, Ana J. García‐Sáez, Abhishek D. Garg, Carmen Garrido, Evripidis Gavathiotis, Motti Gerlic, Sourav Ghosh, Douglas R. Green, Lloyd A. Greene, Hinrich Gronemeyer, Georg Häcker, György Hajnóczky, J. Marie Hardwick, Ygal Haupt, Sudan He, David M. Heery, Michael O. Hengartner, Claudio Hetz, David A. Hildeman, Hidenori Ichijo, Satoshi Inoue, Marja Jäättelä, Ana Janic, Bertrand Joseph, Philipp J. Jost, Thirumala‐Devi Kanneganti and 128 more - Cell Death and Differentiation 2023 cited by 351

  2. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

    Authors: , , - Nature 2002 cited by 4,203

  3. Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vichnou Poirier-Colame, Suzette Delaloge, Frédérique Penault‐Llorca, Sylvain Ladoire, Laurent Arnould, Joanna Cyrta, Marie-Charlotte Dessoliers, Alexander Eggermont, Marco E. Bianchi, Mikaël J. Pittet, Camilla Engblom, Christina Pfirschke, Xavier Préville, Gilles Uzé, Robert D. Schreiber, Melvyn T. Chow, Mark J. Smyth, Enrico Proietti, Fabrice André, Guido Kroemer, Laurence Zitvogel - Nature Medicine 2014 cited by 1,031

  4. The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration

    Authors: , - Frontiers in Immunology 2020 cited by 338

  5. DAMPs, PAMPs and alarmins: all we need to know about danger

    Authors: - Journal of Leukocyte Biology 2006 cited by 2,761

  6. DAMPs from Cell Death to New Life

    Authors: , , - Frontiers in Immunology 2015 cited by 663

  7. Endogenous HMGB1 regulates autophagy

    Authors: , , , , , , , , , , - The Journal of Cell Biology 2010 cited by 953

  8. Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps

    Authors: , , , , , , , , , , , - Journal of Thrombosis and Haemostasis 2014 cited by 525

  9. Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2016 cited by 301

  10. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release

    Authors: , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2012 cited by 707

  11. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures

    Authors: , , , , , , , , , , , - Nature Medicine 2010 cited by 912

  12. High‐mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair

    Authors: , , , , , - Immunological Reviews 2017 cited by 325

  13. Glycyrrhizin Binds to High-Mobility Group Box 1 Protein and Inhibits Its Cytokine Activities

    Authors: , , , , , , , , , - Chemistry & Biology 2007 cited by 607

  14. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion

    Authors: , , , , , , , , - The EMBO Journal 2003 cited by 1,242

  15. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses

    Authors: , , , , , , , , , , , , , , , , , - Nature 2009 cited by 691

  16. Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis

    Authors: , , , , , , , , , , , , - Science Translational Medicine 2018 cited by 213

  17. CXCR4/CXCL12 Activities in the Tumor Microenvironment and Implications for Tumor Immunotherapy

    Authors: , , , , , , , , - Cancers 2022 cited by 118

  18. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4

    Authors: , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2012 cited by 668

  19. The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway

    Authors: , , , , , , - EMBO Reports 2002 cited by 922

  20. High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2008 cited by 608

  21. Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2014 cited by 627

  22. HMGB1 as biomarker and drug target

    Authors: , , , , , - Pharmacological Research 2016 cited by 247

  23. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA

    Authors: , , , , , , , , , , , , - Blood 2007 cited by 465

  24. miR-34a Promotes Vascular Smooth Muscle Cell Calcification by Downregulating SIRT1 (Sirtuin 1) and Axl (AXL Receptor Tyrosine Kinase)

    Authors: , , , , , , , , , , , , - Arteriosclerosis Thrombosis and Vascular Biology 2018 cited by 127